Approaches to transport therapeutic drugs across the blood–brain barrier to treat brain diseases
- 31 January 2010
- journal article
- review article
- Published by Elsevier BV in Neurobiology of Disease
- Vol. 37 (1), 48-57
- https://doi.org/10.1016/j.nbd.2009.07.028
Abstract
No abstract availableKeywords
This publication has 70 references indexed in Scilit:
- Pluronic block copolymers: Evolution of drug delivery concept from inert nanocarriers to biological response modifiersJournal of Controlled Release, 2008
- Antitumour activity of ANG1005, a conjugate between paclitaxel and the new brain delivery vector Angiopep‐2British Journal of Pharmacology, 2008
- A Unique Carrier for Delivery of Therapeutic Compounds beyond the Blood-Brain BarrierPLOS ONE, 2008
- Blood–Brain Barrier Transport of Therapeutics via Receptor-MediationPharmaceutical Research, 2007
- Targeted delivery of proteins across the blood–brain barrierProceedings of the National Academy of Sciences of the United States of America, 2007
- shRNA and siRNA delivery to the brainAdvanced Drug Delivery Reviews, 2007
- Targeted delivery of antibodies through the blood–brain barrier by MRI-guided focused ultrasoundBiochemical and Biophysical Research Communications, 2006
- Pumping iron in the '90sTrends in Cell Biology, 1996
- N-docosahexaenoyl, 3 hydroxytyramine : A dopaminergic compound that penetrates the blood-brain barrier and suppresses appetiteLife Sciences, 1996
- LDL receptor-related protein, a multifunctional ApoE receptor, binds secreted β-amyloid precursor protein and mediates its degradationCell, 1995